Z7G-83792-38997 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-09-08
Dose 1 — Pfizer-BioNTech
2022-09-25
Registered in v-safe
2022-09-25
Health check-in — day 14, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-09-29
Health check-in — day 21, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-10-06
Health check-in — day 28, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-10-13
Survey response — day 35, dose 1, under 3
MedDRA: Nasopharyngitis — Feeling: Fair

Free text: Has a non Covid cold.

MedDRA releases: 2024-11 · check-in free text available
2022-10-20
Survey response — day 42, dose 1, under 3
MedDRA: Nasopharyngitis — Feeling: Fair

Free text: Nasty day care cold from brother.

MedDRA releases: 2024-11 · check-in free text available
2022-12-08
Survey response — 3 months, dose 1, under 3
MedDRA: COVID-19, Nasopharyngitis — Feeling: Good · Be unable to do your normal daily activities

Free text: Several colds and covid

MedDRA releases: 2024-11 · check-in free text available
2023-03-09
Survey response — 6 months, dose 1, under 3
MedDRA: Ear infection — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

MedDRA releases: 2024-11
2023-03-09
Report sent to call center — 6 months, dose 1, under 3
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2023-03-10
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-09-08	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2023-03-09	Unsuccessful

Free text

Release 12 (Under 3) — day 35, dose 1, under 3

2022-10-13

Symptoms: Has a non Covid cold.

Release 12 (Under 3) — day 42, dose 1, under 3

2022-10-20

Symptoms: Nasty day care cold from brother.

Release 12 (Under 3) — 3 months, dose 1, under 3

2022-12-08

Symptoms: Several colds and covid

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	COVID-19	·	·	✓
SD	Ear infection	·	·	✓
SD	Nasopharyngitis	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release